Regent Investment Management LLC - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 63 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Regent Investment Management LLC ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$94,000
-44.7%
20,922
-16.3%
0.02%
-40.5%
Q4 2021$170,000
-6.6%
25,0000.0%0.04%
-15.9%
Q3 2021$182,000
-27.5%
25,0000.0%0.04%
-25.4%
Q2 2021$251,000
+14.1%
25,000
+8.7%
0.06%
+7.3%
Q1 2021$220,000
+0.5%
23,000
+15.0%
0.06%
-9.8%
Q4 2020$219,00020,0000.06%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$9,254,0002.96%
SECTORAL ASSET MANAGEMENT INC 1,053,779$9,347,0000.80%
Pentwater Capital Management LP 4,879,490$43,281,0000.56%
Vivo Capital, LLC 926,449$8,218,0000.48%
Boxer Capital, LLC 1,251,055$11,097,0000.38%
Ikarian Capital, LLC 228,000$2,022,0000.15%
Perceptive Advisors 787,745$6,987,0000.10%
Rock Springs Capital Management LP 367,499$3,260,0000.08%
PURA VIDA INVESTMENTS, LLC 148,949$1,321,0000.07%
PIPER SANDLER & CO. 8,298$74,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders